{"filing":{"accession_number":"0001193125-26-303357","cik":"0001761918","ticker":"ERAS","company_name":"Erasca, Inc.","form":"8-K","filing_date":"2026-07-14","report_date":null,"primary_document":"d371010d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1761918/000119312526303357/d371010d8k.htm"},"events":[{"id":17928,"run_id":16081,"accession_number":"0001193125-26-303357","anchor_item_number":"8.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Erasca entered into an underwriting agreement on July 13, 2026 to issue and sell 31,428,572 shares of common stock at $17.50 per share, with expected net proceeds of approximately $516.0 million (or $593.5 million if the underwriters' 30-day option is exercised in full). This is a registered public offering of equity securities that will dilute existing shareholders. The filing explicitly references the shelf registration statement on Form S-3 and prospectus supplement, confirming this is a registered offering rather than an unregistered private placement, but it remains a material dilutive equity issuance that would significantly affect investor assessment of ownership and capital structure.","company_name":"Erasca, Inc.","ticker":"ERAS","filing_date":"2026-07-14","form":"8-K","submitted_at":null,"items":[{"id":16583,"accession_number":"0001193125-26-303357","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Erasca entered into an underwriting agreement on July 13, 2026 to issue and sell 31,428,572 shares of common stock at $17.50 per share, with expected net proceeds of approximately $516.0 million (or $593.5 million if the underwriters' 30-day option is exercised in full). This is a registered public offering of equity securities that will dilute existing shareholders. The filing explicitly references the shelf registration statement on Form S-3 and prospectus supplement, confirming this is a registered offering rather than an unregistered private placement, but it remains a material dilutive equity issuance that would significantly affect investor assessment of ownership and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-14T21:03:45.537040+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16583,"accession_number":"0001193125-26-303357","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Erasca entered into an underwriting agreement on July 13, 2026 to issue and sell 31,428,572 shares of common stock at $17.50 per share, with expected net proceeds of approximately $516.0 million (or $593.5 million if the underwriters' 30-day option is exercised in full). This is a registered public offering of equity securities that will dilute existing shareholders. The filing explicitly references the shelf registration statement on Form S-3 and prospectus supplement, confirming this is a registered offering rather than an unregistered private placement, but it remains a material dilutive equity issuance that would significantly affect investor assessment of ownership and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-14T21:03:45.537040+00:00","company_name":"Erasca, Inc.","ticker":"ERAS","filing_date":"2026-07-14"}]}